Cargando…
Elevated fecal and serum calprotectin in COVID-19 are not consistent with gastrointestinal symptoms
Intestinal epithelial cell damage caused by SARS-CoV-2 infection was thought to be associated with gastrointestinal symptoms and decreased fecal consistency. The association of the gastrointestinal symptoms with the COVID-19-mediated inflammatory response triggered by the gastrointestinal immune sys...
Autores principales: | Shokri-Afra, Hajar, Alikhani, Ahmad, Moradipoodeh, Bahman, Noorbakhsh, Farshid, Fakheri, Hafez, Moradi-Sardareh, Hemen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578669/ https://www.ncbi.nlm.nih.gov/pubmed/34753964 http://dx.doi.org/10.1038/s41598-021-01231-4 |
Ejemplares similares
-
Serum calprotectin can indicate current and future severity of COVID‐19
por: Shokri‐Afra, Hajar, et al.
Publicado: (2022) -
Fecal calprotectin levels are elevated in transthyretin amyloidosis patients with gastrointestinal manifestations
por: Nakov, Radislav, et al.
Publicado: (2020) -
Diagnostic accuracy of fecal calprotectin in predicting significant gastrointestinal diseases
por: Kan, Yee Man, et al.
Publicado: (2021) -
Fecal Calprotectin and Organic Gastrointestinal Disease: A Systematic Review
por: Asiri, Abdulaziz S, et al.
Publicado: (2023) -
Increased Fecal Calprotectin Is Associated with Worse Gastrointestinal Symptoms and Quality of Life Scores in Children with Cystic Fibrosis
por: Beaufils, Fabien, et al.
Publicado: (2020)